Maternal-Fetal Medicine at New Jersey’s First and Only Comprehensive Fetal Diagnostic and Treatment Center: Dr. Karen Russo on Caring for Mothers and Babies Together - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Maternal-Fetal Medicine at New Jersey’s First and Only Comprehensive Fetal Diagnostic and Treatment Center: Dr. Karen Russo on Caring for Mothers and Babies Together

Dr. Karen Russo admits she isn’t overly formal. The down-to-earth approach is part of what defines the first-of-its-kind Hersh Fetal Diagnostic and Treatment Center in New Jersey.

  • February 2, 2026

  • 4 min

Share

  • 1

    Dr. Karen Russo leads New Jersey's first comprehensive fetal diagnostic and treatment center, focusing on both maternal and fetal health.

  • 2

    The Hersh Fetal Center employs a multidisciplinary approach, coordinating care among various subspecialists in one location.

  • 3

    Dr. Russo emphasizes the importance of communication between the maternal-fetal medicine team, primary obstetricians, and families.

  • 4

    The center provides essential emotional support through social workers and genetic counselors for families facing difficult diagnoses.

  • 5

    Dr. Russo finds fulfillment in delivering hopeful news and ensuring mothers receive comprehensive care without extensive travel.

Original Source(s)

Maternal-Fetal Medicine at New Jersey’s First and Only Comprehensive Fetal Diagnostic and Treatment Center: Dr. Karen Russo on Caring for Mothers and Babies Together

  • February 2, 2026

Related Content

CKM staging faces an early vascular test

Investigators examined Life’s Essential 8 scores and carotid ultrasonography measures across cardiovascular-kidney-metabolic stages in 1,283 young adults.

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

HHS Proposes Mandatory GRAS Notices

Manufacturers would be required to notify the FDA of GRAS determinations under a proposed rule, while HHS and USDA also submitted the first proposed federal definition of ultra-processed foods for final review.